Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

0.5801 -0.0699 (-10.75%)
Streaming Delayed Price Updated: 1:31 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Calidi Biotherapeutics, Inc. Common Stock

< Previous 1 2 3 Next >
Which stocks are moving after the closing bell on Wednesday?
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
These stocks are moving in today's after hours session
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Why Calidi Biotherapeutics (CLDI) Stock Is Down 30%
Calidi Biotherapeutics shares are trading lower by 32% during Friday's session. The company priced its public offering of 5 million shares of common stock at $0.85 per share. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Calidi Biotherapeutics (CLDI) Stock Is Down 13%
Calidi Biotherapeutics shares are trading lower by 12.4% Wednesday. The company announced a $2 million registered direct offering at $1.00 per share. 
Via Benzinga
Why Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q2 2024
CLDI stock results show that Calidi Biotherapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Calidi Biotherapeutics (CLDI) Shares Are Trading Lower
Calidi Biotherapeutics shares are trading lower by 14.3% during Monday's session. The company announced a 1-for-10 reverse stock split. 
Via Benzinga
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Calidi Biotherapeutics is Moving Higher Monday
Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out as we dive into all of the biggest ones worth watching on Wednesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Dow Surges 250 Points; MongoDB Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Why Calidi Biotherapeutics (CLDI) Stock Is Getting Hammered
Calidi Biotherapeutics shares are trading lower by 30.7% during Friday's session. The company announced a definitive agreement for the immediate exercise of certain warrants. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Nasdaq Down 1.5%; Gap Shares Spike Higher
Via Benzinga
US Stocks Mostly Higher; Headline PCE Inflation Matches Estimates
Via Benzinga
Topics Economy
Exposures Interest Rates
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q1 2024
CLDI stock results show that Calidi Biotherapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.